Literature DB >> 9460824

Embodied risk: my body, myself?

A M Kavanagh1, D H Broom.   

Abstract

Risk has become a dominant way to interpret who gets sick and why. A distinction has been drawn between two categories of risk: those arising from the environment, and those resulting from an individual's lifestyle. We identify a third category that might be called corporeal or embodied risk which has received little scholarly attention. Embodied risks are so called because they are located in the body of the person said to be "at risk". Environmental risks are due to something that happens to a person; lifestyle risks occur because of something a person does or does not do, while embodied risks say something about who the person is. To investigate how people experience health risks--especially risks identified as characteristics of their bodies--we conducted detailed interviews with 29 women who were told they had an abnormal Pap smear. All health risks pose problems for people who are diagnosed as "at risk": They must translate probabilistic statements about populations into terms that have personal meaning; they must cope with uncertainty; they must consider what it means to be in danger of developing an illness even though most have no symptoms; and they must mobilise appropriate surveillance and perhaps risk reduction. However, limiting attention to environmental and lifestyle risk (and the distinction between them) neglects the additional challenges posed by corporeal risks: the simultaneous presence of disease now and the possibility of more consequential disease in the future; the necessity to submit to ongoing medical surveillance; a tendency to exacerbate the cartesian split between body and self; and the absence of medical or popular discourses through which to interpret and respond to embodied risk. We call upon medicine and public health practitioners to work together with people who are at risk to formulate languages and approaches that can reflect both scientific accuracy (as it is currently understood), and the needs of people to integrate health threats into their daily personal lives.

Entities:  

Mesh:

Year:  1998        PMID: 9460824     DOI: 10.1016/s0277-9536(97)00188-3

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  17 in total

Review 1.  On the value-ladenness of technology in medicine.

Authors:  B Hofmann
Journal:  Med Health Care Philos       Date:  2001

2.  Beliefs and beyond: what can we learn from qualitative studies of lay people's understandings of cancer risk?

Authors:  Wendy L Lipworth; Heather M Davey; Stacy M Carter; Claire Hooker; Wendy Hu
Journal:  Health Expect       Date:  2010-06       Impact factor: 3.377

3.  For my wellness, not just my illness: North Americans' use of dietary supplements.

Authors:  Mark Nichter; Jennifer Jo Thompson
Journal:  Cult Med Psychiatry       Date:  2006-06

4.  Exploring Explanatory Models of Risk in Breast Cancer Risk Counseling Discussions: NSABP/NRG Oncology Decision-Making Project 1.

Authors:  Christine M Gunn; Barbara Bokhour; Victoria A Parker; Patricia A Parker; Sarah Blakeslee; Hanna Bandos; Christine Holmberg
Journal:  Cancer Nurs       Date:  2019 Jan/Feb       Impact factor: 2.592

5.  [Oxytocin: From a Hormone for Birth to a Social Hormone : The Hormonal Governance of Sociability aka Society].

Authors:  Xenia Steinbach; Sabine Maasen
Journal:  NTM       Date:  2018-03

6.  Works of Illness and the Challenges of Social Risk and the Specter of Pain in the Lived Experience of TMD.

Authors:  Emery R Eaves; Mark Nichter; Cheryl Ritenbaugh; Elizabeth Sutherland; Samuel F Dworkin
Journal:  Med Anthropol Q       Date:  2014-10-21

7.  Diagnosis, narrative identity, and asymptomatic disease.

Authors:  Mary Jean Walker; Wendy A Rogers
Journal:  Theor Med Bioeth       Date:  2017-08

8.  Risking 'Safety': Breast Cancer, Prognosis, and the Strategic Enterprise of Life.

Authors:  Nadine Ehlers
Journal:  J Med Humanit       Date:  2016-03

9.  Biomarkers, the molecular gaze and the transformation of cancer survivorship.

Authors:  Kirsten Bell
Journal:  Biosocieties       Date:  2013-06

10.  A cluster-randomised, parallel group, controlled intervention study of genetic prostate cancer risk assessment and use of PSA tests in general practice--the ProCaRis study: study protocol.

Authors:  Pia Kirkegaard; Peter Vedsted; Adrian Edwards; Morten Fenger-Grøn; Flemming Bro
Journal:  BMJ Open       Date:  2013-03-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.